Your browser doesn't support javascript.
loading
Effect of receiving a customizable brochure on breast cancer patients' knowledge about their diagnosis and treatment: A randomized clinical trial.
Villarreal-Garza, Cynthia; Ferrigno, Ana S; De la Garza-Ramos, Cynthia; Vazquez-Juarez, Daniela; Moreno-Jaime, Brizio; Remolina-Bonilla, Yuly; Segura-Gonzalez, Manuel; Mariscal-Ramirez, Ignacio; Perazzo, Florencia; Garnica-Jaliffe, Georgina; Neciosup-Delgado, Silvia; Conde-Flores, Emilio; Mysler, Shirly; Hernandez-Ayala, Arlette; Barajas-Sanchez, Alondra; Rios Mercado, Maria Del Socorro; Noh-Vazquez, Nelia Maria; Garcia-Rodriguez, Ricardo; Platas, Ana; Tamez-Salazar, Jaime; Mireles-Aguilar, Teresa; Platas, Alejandra.
Afiliación
  • Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.
  • Ferrigno AS; Médicos e Investigadores en la Lucha contra el Cáncer de Mama, Mexico City, Mexico.
  • De la Garza-Ramos C; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.
  • Vazquez-Juarez D; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.
  • Moreno-Jaime B; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.
  • Remolina-Bonilla Y; Hospital Regional del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Leon, Mexico.
  • Segura-Gonzalez M; Hospital de Gineco-Obstetricia No. 4 "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Mariscal-Ramirez I; Unidad Medica de Alta Especialidad del Instituto Mexicano del Seguro Social (IMSS), Merida, Mexico.
  • Perazzo F; Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Mexico.
  • Garnica-Jaliffe G; Section of Oncology, CEMIC Buenos Aires, Buenos Aires, Argentina.
  • Neciosup-Delgado S; Hospital General de Mexico, Mexico City, Mexico.
  • Conde-Flores E; Departamento de Medicina Oncologica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
  • Mysler S; Medical Oncology Research Unit, Medica Sur Hospital and Clinical Foundation, Mexico City, Mexico.
  • Hernandez-Ayala A; Section of Oncology, CEMIC Buenos Aires, Buenos Aires, Argentina.
  • Barajas-Sanchez A; Hospital Regional del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Leon, Mexico.
  • Rios Mercado MDS; Hospital Regional del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Leon, Mexico.
  • Noh-Vazquez NM; Hospital de Gineco-Obstetricia No. 4 "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Garcia-Rodriguez R; Unidad Medica de Alta Especialidad del Instituto Mexicano del Seguro Social (IMSS), Merida, Mexico.
  • Platas A; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.
  • Tamez-Salazar J; Médicos e Investigadores en la Lucha contra el Cáncer de Mama, Mexico City, Mexico.
  • Mireles-Aguilar T; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.
  • Platas A; Médicos e Investigadores en la Lucha contra el Cáncer de Mama, Mexico City, Mexico.
Cancer Med ; 12(14): 15612-15627, 2023 07.
Article en En | MEDLINE | ID: mdl-37317676
BACKGROUND: Patients' lack of knowledge about their own disease may function as a barrier to shared decision-making and well-being. This study aimed to evaluate the impact of written educational materials on breast cancer patients. METHODS: This multicenter, parallel, unblinded, randomized trial included Latin American women aged ≥18 years with a recent breast cancer diagnosis yet to start systemic therapy. Participants underwent randomization in a 1:1 ratio to receive a customizable or standard educational brochure. The primary objective was accurate identification of molecular subtype. Secondary objectives included identification of clinical stage, treatment options, participation in decision-making, perceived quality of information received, and illness uncertainty. Follow-up occurred at 7-21 and 30-51 days post-randomization. CLINICALTRIALS: gov identifier: NCT05798312. RESULTS: One hundred sixty-five breast cancer patients with a median age of 53 years and 61 days from diagnosis were included (customizable: 82; standard: 83). At first available assessment, 52%, 48%, and 30% identified their molecular subtype, disease stage, and guideline-endorsed systemic treatment strategy, respectively. Accurate molecular subtype and stage identification were similar between groups. Per multivariate analysis, customizable brochure recipients were more likely to identify their guideline-recommended treatment modalities (OR: 4.20,p = 0.001). There were no differences between groups in the perceived quality of information received or illness uncertainty. Customizable brochure recipients reported increased participation in decision-making (p = 0.042). CONCLUSIONS: Over one third of recently diagnosed breast cancer patients are incognizant of their disease characteristics and treatment options. This study demonstrates a need to improve patient education and shows that customizable educational materials increase patients' understanding of recommended systemic therapies according to individual breast cancer characteristics.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Middle aged Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: México Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Middle aged Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: México Pais de publicación: Estados Unidos